A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.
Autor: | Kandalaft, Lana E1 lknd@mail.med.upenn.edu, Chiang, Cheryl L1, Tanyi, Janos1, Motz, Greg1, Balint, Klara1, Mick, Rosemarie2, Coukos, George1 |
---|---|
Zdroj: | Journal of Translational Medicine. 2013, Vol. 11 Issue 1, p1-14. 14p. 4 Diagrams. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |